Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
198 studies found for:    Restless Legs Syndrome
Show Display Options
Rank Status Study
21 Recruiting Restless Leg Syndrome and Severe Preeclampsia
Conditions: Restless Leg Syndrome;   Severe Preeclampsia
Intervention:
22 Completed Ropinirole XR (Extended Release) In Patients With Restless Legs Syndrome
Condition: Restless Legs Syndrome
Intervention: Drug: Ropinirole Extended Release (XR)
23 Completed
Has Results
Long-term Study Of Ropinirole In Restless Legs Syndrome
Condition: Restless Legs Syndrome
Interventions: Drug: Placebo;   Drug: Ropinirole
24 Completed Restless Legs Syndrome in Stroke Patients
Conditions: Restless Legs Syndrome;   Stroke;   Transient Ischemic Attack
Intervention:
25 Completed RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
Conditions: Restless Legs Syndrome;   Restless Legs Syndrome (RLS)
Intervention: Drug: ropinirole Extended Release (XR)
26 Recruiting An Efficacy and Safety Evaluation of HORIZANT in Adolescents With Moderate-to-Severe Primary RLS
Condition: RLS
Interventions: Drug: HORIZANT 300 mg;   Drug: HORIZANT 600 mg;   Drug: Placebo
27 Completed
Has Results
Lyrica Dose Response Study With Restless Legs Syndrome (RLS) Patients
Condition: Restless Legs Syndrome
Interventions: Drug: placebo;   Drug: Pregabalin
28 Recruiting A Pharmacokinetic and Safety Evaluation of HORIZANT (Gabapentin Enacarbil) in Adolescents With Moderate-to-Severe Primary RLS
Condition: RLS
Intervention: Drug: HORIZANT 300 mg
29 Withdrawn IV Iron Treatment of Restless Legs Syndrome
Condition: Restless Legs Syndrome
Interventions: Drug: Iron isomaltoside 1000;   Drug: Sodium Chloride 0.9%
30 Withdrawn 12-Week Efficacy And Safety Of Pregabalin In Treating Restless Legs Syndrome (RLS) Subjects
Condition: Restless Legs Syndrome
Interventions: Drug: Placebo;   Drug: pregabalin
31 Unknown  Efficacy of Tyrosine in Restless Legs Syndrome
Condition: Restless Legs Syndrome (RLS)
Intervention: Dietary Supplement: L-Tyrosine
32 Completed An Extension Trial to Investigate Long-Term Treatment With Transdermal Rotigotine in Idiopathic Restless Legs Syndrome
Condition: Restless Legs Syndrome
Intervention: Drug: Rotigotine
33 Withdrawn Vasculaire Leg Compression Device for the Treatment of Restless Legs Syndrome - A Prospective Clinical Study
Conditions: Restless Legs Syndrome,;   Restless Legs,;   Ekbom Syndrome
Intervention: Device: Venous Health Systems Vasculaire Leg Compression Device
34 Completed
Has Results
A Long-Term Extension Trial From Late Phase II of SPM 962 in Patients With Restless Legs Syndrome
Condition: Idiopathic Restless Legs Syndrome
Intervention: Drug: SPM 962
35 Completed Four Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Legs Syndrome
Condition: Restless Legs Syndrome
Intervention: Drug: Rotigotine
36 Completed A Double Blind Crossover Trial of Levetiracetam (Keppra®) and Placebo in the Treatment of Restless Legs Syndrome (RLS)
Condition: Restless Legs Syndrome
Intervention: Drug: Levetiracetam (Keppra)
37 Withdrawn Pregabalin (Lyrica) for the Treatment of Restless Legs Syndrome
Condition: Restless Legs Syndrome
Interventions: Drug: Pregabalin (Lyrica);   Drug: Placebo
38 Completed
Has Results
Rotigotine Effect on All-day Functioning and Quality of Life in Subjects With Moderate to Severe Restless Legs Syndrome (RLS)
Condition: Restless Legs Syndrome
Interventions: Drug: Rotigotine;   Other: Placebo
39 Completed A Clinical Research Study Evaluating Ropinirole Treatment For Restless Legs Syndrome (RLS)
Condition: Restless Legs Syndrome
Intervention: Drug: ropinirole
40 Completed
Has Results
Investigation of Efficacy of incobotulinumtoxinA (Xeomin) in Relieving Symptoms of Restless Leg Syndrome.
Condition: Restless Leg Syndrome
Interventions: Drug: incobotulinumtoxinA;   Drug: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.